United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

crescent pharma ltd - topiramate - oral tablet - 25mg

Canada - English - Health Canada

glenmark pharmaceuticals canada inc. - topiramate - tablet - 25mg - topiramate 25mg - miscellaneous anticonvulsants

Canada - English - Health Canada

glenmark pharmaceuticals canada inc. - topiramate - tablet - 25mg - topiramate 25mg - miscellaneous anticonvulsants

Canada - English - Health Canada

nora pharma inc - topiramate - tablet - 25mg - topiramate 25mg

Canada - English - Health Canada

nu-pharm inc - topiramate - tablet - 25mg - topiramate 25mg - miscellaneous anticonvulsants

New Zealand - English - Medsafe (Medicines Safety Authority)

actavis new zealand limited - topiramate 25mg - film coated tablet - 25 mg - active: topiramate 25mg excipient: aniseed flavour 501007 bp0551 lactose magnesium stearate microcrystalline cellulose opadry white oy-b-28920 amb pregelatinised maize starch purified water saccharin sodium sodium starch glycolate - arrow - topiramate is indicated in adults and children 2 years** and over: · as monotherapy in patients with newly diagnosed epilepsy · for conversion to monotherapy in patients with epilepsy · as add-on therapy in partial onset seizures, generalised tonic-clonic seizures or seizures associated with lennox-gastaut syndrome. **arrow-topiramate tablet range cannot deliver lower doses required for younger paediatric patients .

Canada - English - Health Canada

teva canada limited - topiramate - tablet - 25mg - topiramate 25mg - miscellaneous anticonvulsants

Canada - English - Health Canada

auro pharma inc - topiramate - tablet - 25mg - topiramate 25mg - miscellaneous anticonvulsants

Canada - English - Health Canada

angita pharma inc. - topiramate - tablet - 25mg - topiramate 25mg

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - topiramate, quantity: 25 mg - tablet, film coated - excipient ingredients: magnesium stearate; sodium starch glycollate; microcrystalline cellulose; pregelatinised maize starch; lactose monohydrate; titanium dioxide; hypromellose; polysorbate 80; macrogol 400 - epilepsy: topiramate is indicated in adults and children 2 years and over: - as monotherapy in patients with newly diagnosed epilepsy, - for conversion to monotherapy in patients with epilepsy, and - as add-on therapy in partial onset seizures (with or without secondary generalised seizures), primary generalised tonic-clonic seizures or drop attacks associated with lennox-gastaut syndrome. migraine: topiramate is indicated for the prophylaxis of migraine headache in adults.